Protease inhibitors
Aptivus
The FDA lists this product in 3 strengths and forms.
Composition
- Active ingredients
- TIPRANAVIR 100MG/ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- TIPRANAVIR 250MG · CapsuleNDA021814-001 · Prescription
- TIPRANAVIR 100MG/ML · SolutionThis page
- TIPRANAVIR 100MG/ML · SolutionNDA021822-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA022292.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Aptivus
- Active substance
- tipranavir
- Drug class
- Protease inhibitors
- Route
- Oral
- Dosage form
- Solution
- Applicant
- Boehringer Ingelheim
- Status
- Discontinued
- FDA approval
- 23 Jun 2008
- Application
- NDA022292-001
- RxCUI
- 614593